Europe: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in Europe

The Europe medicaments containing insulin market shrank dramatically to $X in 2021, declining by -38.6% against the previous year. In general, consumption recorded a abrupt curtailment. The level of consumption peaked at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in Europe

In value terms, medicaments containing insulin production expanded rapidly to $X in 2021 estimated in export price. Over the period under review, production showed slight growth. The most prominent rate of growth was recorded in 2016 when the production volume increased by 19%. The level of production peaked at $X in 2017; however, from 2018 to 2021, production stood at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports in Europe

In 2021, the amount of medicaments containing insulin but not antibiotics exported in Europe skyrocketed to X tons, rising by 31% on the previous year's figure. In general, exports, however, recorded a abrupt contraction. The most prominent rate of growth was recorded in 2017 with an increase of 45%. As a result, the exports attained the peak of X tons. From 2018 to 2021, the growth of the exports failed to regain momentum.

In value terms, medicaments containing insulin exports surged to $X in 2021. Overall, exports, however, saw a deep setback. The level of export peaked at $X in 2017; however, from 2018 to 2021, the exports remained at a lower figure.

Exports by Country

Austria (X tons) and Belgium (X tons) were the largest exporters of medicaments containing insulin but not antibiotics in 2021, accounting for approx. 37% and 30% of total exports, respectively. Denmark (X tons) took the next position in the ranking, distantly followed by the UK (X tons). All these countries together took near 18% share of total exports. The Czech Republic (X tons), Norway (X tons), Slovakia (X tons) and Ireland (X tons) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were recorded for Ireland (with a CAGR of +135.0%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing insulin supplying countries in Europe were Austria ($X), Belgium ($X) and the Czech Republic ($X), together comprising 77% of total exports. These countries were followed by Denmark, the UK, Norway, Slovakia and Ireland, which together accounted for a further 9.8%.

Among the main exporting countries, Ireland, with a CAGR of +138.5%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in Europe stood at $X per ton in 2021, surging by 49% against the previous year. In general, the export price saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2016 an increase of 77%. As a result, the export price reached the peak level of $X per ton. From 2017 to 2021, the export prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2021, amid the top suppliers, the country with the highest price was the Czech Republic ($X per ton), while Denmark ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the UK (+19.5%), while the other leaders experienced more modest paces of growth.

Medicaments Containing Insulin Imports

Imports in Europe

Medicaments containing insulin imports dropped rapidly to X tons in 2021, declining by -60.6% compared with 2020 figures. In general, imports recorded a drastic downturn. The most prominent rate of growth was recorded in 2020 with an increase of 407% against the previous year. The volume of import peaked at X tons in 2012; however, from 2013 to 2021, imports failed to regain momentum.

In value terms, medicaments containing insulin imports contracted significantly to $X in 2021. Overall, imports saw a abrupt shrinkage. The pace of growth appeared the most rapid in 2016 with an increase of 160%. Over the period under review, imports attained the maximum at $X in 2013; however, from 2014 to 2021, imports remained at a lower figure.

Imports by Country

Denmark (X tons) represented roughly 97% of total imports in 2021.

Denmark was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of +27.5% from 2012 to 2021. From 2012 to 2021, the share of Denmark increased by +96 percentage points, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Denmark ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Europe.

In Denmark, medicaments containing insulin imports increased at an average annual rate of +20.7% over the period from 2012-2021.

Import Prices by Country

In 2021, the import price in Europe amounted to $X per ton, growing by 95% against the previous year. In general, the import price showed a remarkable increase. The most prominent rate of growth was recorded in 2018 when the import price increased by 201% against the previous year. As a result, import price attained the peak level of $X per ton. From 2019 to 2021, the import prices remained at a somewhat lower figure.

As there is only one major supplying country, the average price level is determined by prices for Denmark.

From 2012 to 2021, the rate of growth in terms of prices for Denmark amounted to -5.3% per year.

Source: IndexBox Market Intelligence Platform

Frequently Asked Questions (FAQ) :